These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation. Duan X; Yang L; Dong S; Xin R; Chen G; Guo L Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Zheng ZH; Li XY; Ding J; Jia JF; Zhu P Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691 [TBL] [Abstract][Full Text] [Related]
12. Histocompatibility testing of cultivated human bone marrow stromal cells - a promising step towards pre-clinical screening for allogeneic stem cell therapy. Koppula PR; Chelluri LK; Polisetti N; Vemuganti GK Cell Immunol; 2009; 259(1):61-5. PubMed ID: 19577229 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910 [TBL] [Abstract][Full Text] [Related]
17. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164 [TBL] [Abstract][Full Text] [Related]
18. Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model. Wang Y; Chen X; Armstrong MA; Li G J Orthop Res; 2007 Jul; 25(7):926-32. PubMed ID: 17415789 [TBL] [Abstract][Full Text] [Related]
19. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [TBL] [Abstract][Full Text] [Related]
20. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Zhou HP; Yi DH; Yu SQ; Sun GC; Cui Q; Zhu HL; Liu JC; Zhang JZ; Wu TJ Transplant Proc; 2006 Nov; 38(9):3046-51. PubMed ID: 17112896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]